Former NHS chief to chair Cancer Research UK board

Former chief executive of NHS England Lord Simon Stevens has been appointed by Cancer Research UK (CRUK) to chair its board.

He is to take on the role in October and replaces Leszek Borysiewicz, who is stepping down after almost seven years in the role.

Stevens stood down as NHS chief executive, after more than seven years leading the organisation, in 2021 and became an independent crossbench member of the House of Lords in the same year.

He has worked in the health sector for three decades, including stints at the Department of Health and as a policy advisor 10 Downing Street during Tony Blair’s premiership.

From 1998 he spent four years as a Labour councillor in Lambeth and has been a senior executive at private health firm UnitedHealth Group.

“Having worked alongside Cancer Research UK over a number of years, I’ve long admired the charity’s exceptional leadership in advancing the frontiers of cancer science and care,” said Stevens.

“My family - like so many others - has been touched by cancer, and we’ve seen first hand the amazing progress in modern cancer therapies.

“It’ll therefore be a privilege as incoming chair of the council of trustees to help support Cancer Research UK’s inspirational scientists, clinicians, staff and volunteers as the organisation delivers its new strategy for the coming decade.”



The charity’s CEO Michelle Mitchell added: “On behalf of the Trustees, staff, volunteers and supporters of the charity, I would like to share my gratitude for the outstanding contribution that Sir Leszek has made during his tenure and for the incredible personal support and encouragement he has given to me and many of the team at CRUK.

“We look forward to welcoming Simon to CRUK and working with him to implement our exciting new strategy."

    Share Story:

Recent Stories


Beyond the funding squeeze: Using equities to secure your charity’s future
With charities facing increasing financial pressure and traditional income streams under strain, making investments work harder has never been more important. M&G’s Richard Macey and Michael Stiasny join Charity Times to discuss why equities remain a vital long-term asset class for charities, how organisations can balance income generation and growth, and the opportunities the current market environment may offer to help strengthen financial resilience.

Charity Times Awards 2023

Charity Times video Q&A: In conversation with Hilda Hayo, CEO of Dementia UK
Charity Times editor, Lauren Weymouth, is joined by Dementia UK CEO, Hilda Hayo to discuss why the charity receives such high workplace satisfaction results, what a positive working culture looks like and the importance of lived experience among staff. The pair talk about challenges facing the charity, the impact felt by the pandemic and how it's striving to overcome obstacles and continue to be a highly impactful organisation for anybody affected by dementia.